Monday, November 4, 2024

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World’s no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India’s widespread dry skin concerns.

·        Almost 1 in 2 consumers amongst the general population suffer from dry skin, as per dermatologists’ opinion

·        82% of surveyed dermatologists state that patients feel anxious about going out in public, for the fear of their skin being exposed

·        88% of dermatologists link skin flare-ups to environmental factors, highlighting the need for specialized skincare solutions.

 

Hyderabad: November 2024 — Bayer’s Consumer Health Division proudly introduces Bepanthen, the world’s leading skincare brand*, to the Indian market along with a survey conducted by Ipsos** among Indian dermatologists, emphasizing the high occurrence of dry skin among general population. 82% of dermatologists agree that patients tend to brush off recurrent dry skin as "just dry skin" without knowing there could be an underlying skin condition.

 

The 2024 Bepanthen Survey on Dry Skin conducted across 7 cities brings insightful narratives through dermatologist’s lens on the prevalence of dry skin conditions in our country with findings that reinforce the critical need to address skincare issues experienced by individuals suffering from dry, irritated, and sensitive skin. With 75-years of innovation and effectiveness, Bepanthen aims to provide unmatched relief for dry and sensitive skin.

 

According to The Bepanthen Dry Skin Survey, 9 out of 10 dermatologists that were surveyed agreed there is currently a knowledge gap among adult patients about recurrent dry skin conditions and the right way to manage it. Amongst dry skin sufferers, visiting the dermatologist, almost 1 in 3 patients have recurrent dryness. As per dermatologists, dry skin sufferers tend to use general moisturizers/home remedies before consulting an expert.

 

In response to these findings, Bayer Consumer Health has launched Bepanthen, World’s No 1 Skincare brand* in India. Bepanthen offers a specialized range of moisturizers and cleansers for both face and body, designed to meet the unique needs of Indian skin. With a clean, fragrance-free, and paraben-free formula enriched with Pro-Vitamin B5 and Prebiotic, Bepanthen not only provides immediate relief for dry, irritated, and sensitive skin but also supports skin’s own regeneration and long-term skin health. By addressing the critical gaps identified in the survey, Bepanthen is dedicated to helping individuals achieve healthier skin and closing the knowledge gap surrounding dry skin conditions.

 

Sandeep Verma, Country Head for India, Bangladesh, and Sri Lanka at Bayer’s Consumer Health Division, commented, “What is interesting to note in the 2024 Bepanthen Survey on Dry Skin, is sometimes people cannot distinguish between just dry skin and chronic dry skin, even though some of them look up the internet for more information. We at Bayer aim to bridge this knowledge gap, and aid people in understanding when and how they can seek help. Bepanthen products go beyond just moisturizing, they are designed to enhance the quality of life for individuals who often-overlook their skin health. Bepanthen’s entry into India marks a significant step in our mission to provide premium science-backed skincare solutions.”

 

Dr. Ratnapal Shah, Senior Dermatologist, MBBS DVD added, “The clinical efficacy of Bepanthen range in managing eczema and dermatitis is highly significant. Effectively addressing these issues is crucial for overall skin health. Many patients are unaware of the importance of proper care for dry and irritated skin, which often worsens these conditions. Understanding how to soothe and protect the skin can help reduce flare-ups and maintain long-term skin wellness.”

 

Globally recognized for its innovation, Bepanthen’s medicated moisturizers are clinically proven to be as effective as 1% hydrocortisone for atopic eczema and dermatitis-prone skin. 86% of dermatologists agree that combining medicated moisturizers with body and face washes offers a comprehensive treatment for sensitive skin.

 

Bepanthen has 75 years of global expertise backed by 11 clinical studies and is launched in India with a holistic skincare range for dry skin management. It is dermatologically approved with clean formulations which are free of colorants, fragrance and paraben. Bepanthen starts working from the 1st application. The range includes 4 products each with unique formulations of Pro-Vitamin B5 and Prebiotics. It has a daily moisturizing cream, gentle cleansers for body & face, and an itch relief cream that repairs extremely dry skin and it is a steroid-free formula for eczema-prone skin.  80% of dermatologists prefer prescribing steroid-free formulations. Bepanthen, the world’s leading skincare expert is committed to alleviating dry, irritated, and sensitive skin.

 

Key insights from dermatologists surveyed in the Bepanthen Dry Skin Survey:

·       Dermatologists believe that almost 1 in 2 (on an average of 47%) of Indians suffer from dry skin.

·       30% people, who consult a dermatologist, suffer from dry skin-related conditions.

·       Almost 1 in 3 (32%) dry skin sufferers, visiting the dermatologist, have recurrent dry/irritated/sensitive skin. 

·       82% of dermatologists report patients feel anxious about going out in public for the fear of their skin being exposed.

·       Over 50% dermatologists state that patients tend to become more irritable due to constant physical distress.

·       93% dermatologists opine that there is currently a knowledge gap among adult patients suffering from recurrent dry/irritated/sensitive skin conditions and the right way to manage it.

·       88% of dermatologists attribute flare-ups to environmental factors, like cold and dry weather.

·       80% of dermatologists believe up to 30% of recurrent sufferers have the condition year-round.

·       75% of dermatologists identify individuals aged 25 to 40 as most prone to recurrent dry, irritated, sensitive skin.

·       80% dermatologists agree that they will prescribe a cortisone-free medicated moisturizer.

 

Listed below are additional insights and statistics based on dermatologists surveyed in the ‘Bepanthen Dry Skin Survey’

No comments:

Post a Comment

GIVE REVIEW ABOUT OUR UPDATE OR REQUEST

Adroit Industries (India) Limited IPO Opens on Wednesday, September 23, 2026 Total Offer Size- Up to 1,12,47, 000 Equity Shares of face value of ₹10 each Fresh Issue Size - Up to 98,97,000 Equity Shares OFS size - Up to 13,50,000 Equity Shares Total Size - ₹ 150.71 Crore (At Upper Price Band) Price Band - ₹ 126 - ₹ 134 per share Lot Size – 111 Equity Shares Mumbai, September 21, 2026 - Adroit Industries (India) Limited is a vertically integrated manufacturer of propeller shafts and torque-transmission components with over four decades of operational experience, serving automotive, primarily commercial vehicles, and non-automotive applications, including defence and emergency services, heavy equipment and off-highway machinery and industrial equipment across more than 32 countries, proposes to open its Initial Public Offering on Wednesday, September 23, 2026 aiming to raise ₹ 150.71 Crores (At Upper Price Band), with shares to be listed on the BSE & NSE. The offer size is up to 1,12,47,000 Equity Shares with a face value of ₹10 each with a price band of ₹126 - ₹134 Per Share. Equity Share Allocation QIB Portion – Not more than 50.00% of the Offer Non-Institutional Investors - Not less than 15.00% of the Offer Retail Individual Investors - Not less than 35.00% of the Offer The net proceeds from the IPO will be utilized for funding capital expenditure by the company towards procurement of machinery and equipment for enhancement of operations at the Dewas Facility and transportation vehicles for movement of goods between the manufacturing facilities, investment in its subsidiary Adroit Driveshafts Private Limited for capital expenditure towards machinery and equipment at the Pithampur Facility and transportation vehicles for movement of goods between the manufacturing facilities, investment in the subsidiary for repayment or pre-payment, in full or in part, of certain outstanding borrowings availed by it, and general corporate purposes. The anchor bidding is on Tuesday, September 22, 2026. The offer will open on Wednesday, September 23, 2026 and will close on Friday, September 25, 2026. The Book Running Lead Manager to the Offer is Choice Capital Advisors Private Limited and the Registrar is Bigshare Services Private Limited. Mr. Saurabh Sangla, Chairman and Managing Director of Adroit Industries (India) Limited “expressed, The upcoming IPO marks a new phase for the Company. Over the years we have built vertically integrated capabilities spanning forging, precision machining, heat treatment, assembly, balancing and testing, and expanded our portfolio to over 5,000 SKUs of driveline components supplied to customers in more than 32 countries. Going forward, our focus will be on strengthening capacity across our manufacturing facilities, improving operational efficiency, deepening engagement with the Distributors, OEMs and Tier-1 customers across our export and domestic markets and broadening our automotive and non-automotive applications. The IPO will support our plans as we continue to strengthen the business and pursue long-term growth.” Mr. Ratiraj Tibrewal, Director of Choice Capital Advisors Private Limited said, “Adroit Industries (India) Limited has built an export-led driveline business over four decades, with vertically integrated manufacturing and a diversified customer base across automotive and non-automotive applications. The upcoming IPO marks an important step in the Company’s journey as it enters the public markets. We believe the Company’s integrated manufacturing capabilities, long-standing customer relationships and expanding product portfolio provide a foundation for its next phase of growth. We are pleased to be associated with Adroit Industries (India) Limited as it takes this step towards becoming a publicly listed company.” About Adroit Industries (India) Limited Adroit Industries (India) Limited is a vertically integrated manufacturer and supplier of propeller shafts – also known as drive shafts or cardan shafts – and related torque-transmission components. Its portfolio spans over 5,000 SKUs of driveline components, including propeller shaft assemblies, yokes, shafts, companion flanges, universal joints and accessories, supplied to automotive applications, largely commercial vehicles and SUVs, and to non-automotive applications spanning defence and emergency services, heavy equipment and off-highway machinery and industrial equipment. The Company operates three manufacturing facilities in Madhya Pradesh – Dewas Facility i.e for die making and forging processes, Pithampur Facility for machining and assembly, operated by its subsidiary Adroit Driveshafts Private Limited, and Sanwer Road Facility for certain finishing operations– with end-to-end in-house capabilities covering forging, precision machining, heat treatment, assembly, balancing and testing. The facility is certified under IATF 16949, ISO 9001, ISO 14001 and ISO 45001. With operations commencing in 1966, the Company has evolved into an export-led driveline components manufacturer, with 95.39% of Fiscal 2026 product sales derived from outside India across more than 32 countries, supported by a Canadian subsidiary for North American customer engagement, and serving 185 customers in Fiscal 2026 through distributors, Tier-1 driveline component suppliers and OEMs. In FY26, The Company achieved a Revenue from operations of ₹1,399.43 million, EBITDA of ₹387.10 million & PAT of ₹261.58 million. Disclaimer: Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

Adroit Industries (India) Limited IPO Opens on Wednesday, September 23, 2026 Total Offer Size- Up to 1,12,47, 000 Equity Shares of face valu...